Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
JPH1 encodes junctophilin 1 (661 aa). Junctophilins contribute to the formation of junctional membrane complexes (JMCs) which link the plasma membrane with the endoplasmic or sarcoplasmic reticulum in excitable cells. Highest expression in Muscle Skeletal (140.0 TPM) and Brain Cerebellar Hemisphere (35.1 TPM).
Congenital myopathy 25 is associated with mutations in the JPH1 gene on chromosome 8.
JPH1 is classified as a druggable target (Ion Channel category) with score 0.0.
Genetic testing for JPH1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for congenital myopathy 25 has been reported in the published literature.
No clinical trials have been registered for congenital myopathy 25.
64 publications have been identified in PubMed for congenital myopathy 25. Research spans Epidemiology / Natural History (34%), Case Report / Case Series (31%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 22 | 34% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:21 AM UTC
Online Mendelian Inheritance in Man
Patient case studies
20 |
31% |
Laboratory research | 10 | 16% |
Testing and diagnosis research | 4 | 6% |
Research summaries | 4 | 6% |
Clinical study results | 2 | 3% |
Other research | 1 | 2% |
New treatment approaches | 1 | 2% |
Bektaş Öntaş H (2026). [PMID: 41240414](https://pubmed.ncbi.nlm.nih.gov/41240414/). *Eur J Paediatr Neurol*. [Epidemiology / Natural History]
Michael E (2026). [PMID: 41159764](https://pubmed.ncbi.nlm.nih.gov/41159764/). *Ann Neurol*. [Epidemiology / Natural History]
Hubska J (2026). [PMID: 41816211](https://pubmed.ncbi.nlm.nih.gov/41816211/). *Front Endocrinol (Lausanne)*. [Case Report / Case Series]
Yoshimi A (2026). [PMID: 42156210](https://pubmed.ncbi.nlm.nih.gov/42156210/). *Mol Genet Metab*. [Case Report / Case Series]
Fortin J (2026). [PMID: 41669957](https://pubmed.ncbi.nlm.nih.gov/41669957/). *Mov Disord*. [Epidemiology / Natural History]
Jacob M (2026). [PMID: 40497796](https://pubmed.ncbi.nlm.nih.gov/40497796/). *Brain*. [Basic Science / Preclinical]
Grünert SC (2026). [PMID: 41554131](https://pubmed.ncbi.nlm.nih.gov/41554131/). *J Inherit Metab Dis*. [Epidemiology / Natural History]
Smolka W (2026). [PMID: 41895194](https://pubmed.ncbi.nlm.nih.gov/41895194/). *J Craniomaxillofac Surg*. [Clinical Trial Publication]
Marozzi J (2026). [PMID: 41285026](https://pubmed.ncbi.nlm.nih.gov/41285026/). *Hum Reprod*. [Epidemiology / Natural History]
Firouzi A (2026). [PMID: 41881850](https://pubmed.ncbi.nlm.nih.gov/41881850/). *Catheter Cardiovasc Interv*. [Case Report / Case Series]